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he actin cytoskeleton is locally regulated for func-
tional specializations for cell motility. Using quanti-
tative ﬂuorescent speckle microscopy (qFSM) of
migrating epithelial cells, we previously deﬁned two dis-
tinct F-actin networks based on their F-actin–binding
proteins and distinct patterns of F-actin turnover and
movement. The lamellipodium consists of a treadmilling
F-actin array with rapid polymerization-dependent retro-
grade ﬂow and contains high concentrations of Arp2/3
and ADF/coﬁlin, whereas the lamella exhibits spatially
random punctae of F-actin assembly and disassembly
T
 
with slow myosin-mediated retrograde ﬂow and contains
myosin II and tropomyosin (TM). In this paper, we micro-
injected skeletal muscle 
 
 
 
TM into epithelial cells, and us-
ing qFSM, electron microscopy, and immunolocalization
show that this inhibits functional lamellipodium formation.
Cells with inhibited lamellipodia exhibit persistent leading
edge protrusion and rapid cell migration. Inhibition of
endogenous long TM isoforms alters protrusion persis-
tence. Thus, cells can migrate with inhibited lamellipodia,
and we suggest that TM is a major regulator of F-actin
functional specialization in migrating cells.
 
Introduction
 
Cell migration is thought to occur by a coordinated cycle of lead-
ing edge protrusion in the direction of migration, substrate adhe-
sion of the protrusion, generation of tension on new adhesions to
advance the cell body, and de-adhesion of the trailing cell rear.
F-actin is required for each step of the cycle. Spatio-temporally
coordinated regulation of the interaction of F-actin with specific
binding proteins and myosin motors is required for the actin
cytoskeleton to perform such diverse mechanical functions.
Using computational quantitative analysis of fluorescent
speckle microscopy (FSM) movies of F-actin in migrating epi-
thelial cells, we showed two distinct arrays of F-actin exist at
the leading edge, the lamellipodium, and the lamella (Ponti et
al., 2004). Quantitative FSM (qFSM) analysis produces spatio-
temporal maps of F-actin assembly/disassembly (kinetics) and
motion (kinematics) by tracking the position and intensity
fluctuations  of fluorescent actin speckles in FSM movies
(Waterman-Storer et al., 1998, Danuser and Waterman-Storer,
2003, Vallotton et al., 2003, Ponti et al., 2003, 2004). The two
distinct F-actin arrays are operationally defined by four crite-
ria: (1) the molecules that differentially localize to them (their
molecular signatures), (2) the spatial organization of the rates
of F-actin assembly/disassembly (their kinetic signatures)
 
,
 
 and
(3) the rate and (4) mechanism of F-actin meshwork transloca-
tion (their kinematic signatures; Ponti et al., 2004).
The lamellipodium kinetic signature is characterized by
fast F-actin polymerization subjacent to the leading edge, fol-
lowed by near complete filament depolymerization a few mi-
crometers back, creating a 2–4-
 
 
 
m-wide treadmilling actin
array abutting the cell edge (Watanabe and Mitchison, 2002;
Ponti et al., 2004). This kinetic behavior may be mediated by
the signature molecules concentrated in this region, Arp2/3 and
ADF/cofilin, with F-actin nucleated from existing filaments by
the Arp2/3 complex and ADF/cofilin mediating filament severing
(Bailly et al., 1999; Svitkina and Borisy, 1999; Pollard et al.,
2000). Severed filaments contribute to depolymerization from
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“pointed” ends (Carlier et al., 1997; Svitkina and Borisy, 1999)
and creation of new fast growing “barbed” ends (Ichetovkin et
al., 2002). Monomer addition at F-actin barbed ends is thought
to provide the force for leading edge protrusion (Tilney et al.,
1981; Mogilner and Oster, 2003) and also drives the rapid
retrograde flow (
 
 
 
1 
 
 
 
m/min) of the F-actin meshwork that
marks the kinematic signature of the lamellipodium (Water-
man-Storer et al., 1998; Salmon et al., 2002; Vallotton et al.,
2003; Ponti et al., 2004).
The lamella of migrating epithelial cells comprises an
area within 3–15 
 
 
 
m from the cell edge. Lamella actin kinet-
ics are marked by spatially discrete foci of polymerization
and depolymerization, which aphasically cycle between these
states (Ponti et al., 2004). Myosin II–dependent (Lin et al.,
1996; Ponti et al., 2004) slow retrograde flow (
 
 
 
0.3 
 
 
 
m/min;
Waterman-Storer et al., 1998; Salmon et al., 2002) defines the
kinematic signature of the lamella F-actin, which may be me-
diated by the other signature molecule in this region, tropomy-
osin (TM; Ponti et al., 2004). Both myosin II and TM are ab-
sent from the lamellipodium (Lazarides, 1976; DesMarais et
al., 2002; Ponti et al., 2004). In the cell body, F-actin un-
dergoes myosin-dependent anterograde flow, which meets
F-actin retrograde flow from the lamella in a region of fila-
ment depolymerization but little actin motion termed the “con-
vergence zone” (Gupton et al., 2002; Salmon et al., 2002).
The junction between the lamellipodium and lamella is
marked by substrate adhesions (Izzard and Lochner, 1980;
Ponti et al., 2004), which are transmembrane complexes of in-
tegrins, signaling proteins, and actin binding proteins that
translate actomyosin contraction in the lamella into cell pulling
forces on the ECM.
We showed that persistent leading edge advance was
associated with forward expansion of the lamella F-actin
network, whereas kinetic and kinematic changes in the la-
mellipodium correlated only with cyclic, short-lived leading
edge protrusion and retraction (Ponti et al., 2004). This find-
ing suggested the lamella actin array is critical to productive
cell advance, questioning the importance of the lamellipo-
dium for cell migration. In the present work, we sought to
alter the identity of F-actin arrays near the leading edge of
migrating cells to determine their functional contribution to
cell motility.
TM is a good candidate protein whose mislocalization
could change the identity of F-actin arrays in migrating cells.
In vitro studies have shown nonmuscle and skeletal TMs block
Arp2/3 nucleating (Blanchoin et al., 2001) or ADF/cofilin sev-
ering of F-actin (Bernstein and Bamburg, 1982) and inhibit
pointed-end depolymerization (Broschat, 1990). TMs regulate
myosin II interactions with F-actin as characterized in skeletal
muscle. Thus, TMs could be central to distinguishing lamella
and lamellipodium F-actin arrays by inhibiting F-actin binding
by lamellipodium signature proteins (DesMarais et al., 2002)
and promoting association of lamella proteins like myosin II.
Here, we microinjected purified skeletal muscle 
 
 
 
TM (skTM)
as a specific tool to alter distinct F-actin arrays near the lead-
ing edge of migrating cells to determine their contribution to
cell migration.
 
Results
 
High levels of skTM localize to the 
leading edge of PtK
 
1
 
 cells
 
We used PtK
 
1
 
 epithelial cells, whose F-actin organization,
kinetics, and kinematics we have extensively characterized
(Wittmann et al., 2003; Ponti et al., 2004). In small islands
(Fig. 1 A), the noncontacted edges of these cells exhibit protru-
sive and retractive activity and as a group undergo random mo-
tility at 0.55 
 
  
 
0.03 
 
 
 
m/min. The F-actin cytoskeleton consists
of a dense F-actin meshwork at the cell edge that thins at 2–4
 
 
 
m from the edge, followed by transverse bundles (Fig. 1 D;
Wittmann et al., 2003; Ponti et al., 2004). Whole-mount EM re-
veals two morphologically distinct networks near the cell edge
(Fig. 1 F). In the region 2–4 
 
 
 
m from the cell edge is a homog-
enous isotropic filament network (Fig. 1 G), whereas more
proximal regions contain denser filament bundles that extend
toward the leading edge and are interspersed by isotropic net-
work. These structurally distinct networks likely correspond to
the lamellipodium and lamella, respectively, as defined previ-
ously by their molecular, kinetic, and kinematic signatures
(Ponti et al., 2004).
Nonmuscle cells generally express multiple TM isoforms
differentially spliced from four genes (Lin et al., 1997). Exon-
specific antibodies revealed that PtK
 
1
 
 cells expressed at least
one long (
 
 
 
39 kD) and one short (
 
 
 
36 kD) isoform of TM,
one of which was recognized by the CG3 monoclonal antibody
specific for TM5 or TM5NM (Fig. 1 B). Immunofluorescence
using a long TM-specific monoclonal antibody (TM311; Fig. 1
D) or a TM polyclonal antibody to long and short isoforms
(RB14; not depicted) showed TM localization to F-actin bun-
dles in the cell body and lamella, but exclusion 2–4 
 
 
 
m from
the leading edge (Fig. 1 D) as reported for other cell types
(DesMarais et al., 2002).
To increase TM levels in PtK
 
1
 
 cells, we microinjected
rabbit psoas 
 
 
 
TM (skTM; Fig. 1 C) at a needle concentration
of 
 
 
 
140 
 
 
 
M resulting in an intracellular concentration well
above the F-actin Kd. Using a striated muscle TM-specific an-
tibody, we found that skTM localized to F-actin in the lamella
and bundles in the cell center, but in contrast to endogenous
TMs, skTM extended to the leading edge (Fig. 1 E). This anti-
body did not recognize endogenous TMs in PtK
 
1
 
 cells (Fig. 1
B). Cells containing skTM showed increased F-actin bundles
extending from the cell body to the leading edge or beyond,
creating filopodial-like protrusions that were not present in
control cells (Fig. 1 E, arrowhead). EM of skTM-injected cells
revealed loss of the homogenous, isotropic filament array typi-
cal of the lamellipodium, and filaments in an ordered array of
bundles (Fig. 1, H and I, yellow) oriented toward the leading
edge similar to the lamella of control cells, often with more
filopodia-like protrusions (Fig. 1 G, arrows). Stereo-imaging
indicated that cells injected with skTM have a much thinner
lamella than control cells (Fig. S1, available at http://www.
jcb.org/cgi/content/full/jcb.200406063/DC1).
To determine how mislocalization of TM to the leading
edge affected the organization of F-actin into lamellipodium
and lamella, we further characterized the leading edges of 
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skTM-injected cells according to their: (a) molecular signa-
tures, (b) spatial organization of the rates of F-actin assembly/
disassembly (kinetic signatures), and (c) rate and (d) mecha-
nism of F-actin meshwork translocation (kinematic signatures).
 
skTM depletes Arp2/3 and ADF/cofilin 
from the leading edge and decreases 
local free barbed filament ends
 
To determine if skTM affected Arp2/3 and ADF/cofilin target-
ing to the cell edge, their localizations were examined by im-
munofluorescence. Control cells had Arp2/3 and ADF/cofilin
throughout the cell, with the highest concentration within 2–4
 
 
 
m from the leading cell edge (Fig. 2, A and C), as previously
reported (Welch et al., 1997; Svitkina and Borisy, 1999; Ponti
et al., 2004). In contrast, cells containing skTM had less Arp2/3
and ADF/cofilin at the leading edge (Fig. 2, B and D). To quan-
tify this, fluorescence intensity along line scans from the cell
edge into the cell center were measured (13 cells per treatment,
three measurements per cell). This conclusively showed cells
containing skTM had a twofold decrease in Arp3 and ADF/co-
filin relative to F-actin along these profiles (Fig. 2 E) due to
major decreases in Arp3 and ADF/cofilin near the cell edge
and increases in F-actin toward the cell center (Fig. 2, F and G).
Because Arp2/3 and ADF/cofilin are thought to supply
polymerization-competent free barbed filament ends to the
lamellipodium (for review see Pollard et al., 2000), we analyzed
the localization and amount of free barbed ends (see Materials
and methods). In control cells, free barbed ends were in a nar-
row rim along the leading edge (Symons and Mitchison, 1991),
and at the end of F-actin bundles, likely at substrate adhesions
(Fig. 3 A). In contrast, free barbed ends at the leading edge
were dramatically reduced in cells containing skTM (Fig. 3 C),
Figure 1. skTM localizes to F-actin throughout the cell.
(A) Island of PtK1 epithelial cells. (B) Western blot analy-
sis of PtK1 lysate for TM isoforms. (C) Purified skTM seen
by Coomassie blue. Numbers refer to mass markers.
(D) Immunolocalization of long TMs (TM311 monoclonal)
and F-actin (fluorescent phalloidin) in a PtK1 cell. TM is
excluded from the cell edge. (E) PtK1 cell injected with
skTM and immunolabeled with muscle-specific CH1 anti-
body and costained for F-actin. Filopodial-like protrusions
occur in cells injected with skTM (arrowhead). Merged
images in D and E are from boxed regions, with F-actin
and TM in red and green, respectively. Whole mount EM
of control (F and G) and skTM-injected (H and I) cells.
G and I show enlargements of F and H, respectively.
Near the cell edge, an isotropic network and small vertical
ruffles (arrows) are present, followed by the lamella with
dense population of bundles (yellow) oriented toward the
cell margin. A horizontal dense belt of filaments (red)
delineate the cell body from the lamella (red). In the in-
jected cell (H), the only visible network is comprised of
oriented bundles (yellow) and filopodia-type protrusions
(arrow in I). Bars: (F and H) 2.4  m; (G and I) 5.0  m. 
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although some persisted at filopodial tips and in adhesions (Fig.
3 B). Analysis of fluorescence along line scans from the leading
edge into the cell center quantitatively confirmed this (Fig. 3, C
and D, three measurements per cell, 13 cells per treatment).
Immunofluorescence localization of the barbed-end pro-
tecting proteins Mena or VASP or the “leaky cap” mDia2
showed no differences in cells containing skTM versus con-
trols (Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200406063/DC1), suggesting barbed ends remaining in
skTM cells may be protected. The localization of filamin and
cortactin was unaffected by skTM (Fig. 3), indicating a specific
effect on Arp2/3 and cofilin localization.
 
Kinetic and kinematic analysis of F-actin 
dynamics reveals skTM inhibits 
lamellipodium formation
 
To determine the effects of skTM on the kinetics and kinematics
of the actin cytoskeleton, we performed time-lapse spinning-disk
confocal imaging of cells injected with low levels of X-rho-
damine–labeled actin (Fig. 4 C and Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200406063/DC1) and performed
qFSM image analysis of protrusive cells (Waterman-Storer et al.,
1998; Danuser and Waterman-Storer, 2003; Vallotton et al., 2003;
Ponti et al., 2003). Control cells displayed a treadmilling lamelli-
podial array seen as a discrete narrow band of rapid F-actin poly-
merization (Fig. 4 A, red arrow) along the leading edge juxtaposed
against a narrow band of rapid F-actin depolymerization (Fig. 4 A,
green, 
 
n
 
 
 
 
 
 4 cells; and Video 2, available at http://www.jcb.org/
cgi/content/full/jcb.200406063/DC1). In the lamella, 1–3-
 
 
 
m-
diam foci of polymerization and depolymerization were inter-
mixed (Fig. 4 A and Video 2; Ponti et al., 2003, 2004). In contrast,
qFSM analysis of F-actin kinetics in cells containing skTM re-
vealed a single region of lamella-like kinetic behavior throughout
the cell (Fig. 4 A, skTM; and Video 2, 
 
n
 
 
 
  
 
4 cells). These cells
completely lacked the bands of polymerization and depolymeriza-
tion at the leading edge typical of the treadmilling actin array of
the lamellipodium. Similarly, inhibition of Arp2/3 by the CA
domain of the Arp2/3 activator N-Wasp (Strasser et al., 2004)
caused the disappearance of the juxtaposed bands of polymeriza-
tion and depolymerization at the cell edge (Fig. 4 A, GFP-CA). It
should be noted that the dramatic difference in F-actin kinetics
produced by these different perturbations are not at all apparent
from the morphology of the cell edge as seen by phase contrast,
but are only revealed by qFSM analysis.
Figure 2. skTM depletes Arp2/3 and ADF/cofilin from the leading edge of PtK1 cells. (A) Immunolocalization of Arp3 and F-actin (fluorescent phalloidin)
in control cells (A) and cells injected with skTM (B). Lines in A are examples of one region where fluorescence intensity line scans were taken to produce
the type of data seen in E and F. ADF/cofilin and F-actin localization in control cells (C) and cells injected with skTM (D). Boxed regions are magnified in
the Merge column, with Arp3 (A and B) and ADF/cofilin (C and D) in green and F-actin in red. (E) Average fluorescence intensity ratio of Arp3/F-actin
and cofilin/F-actin in control and skTM-injected cells measured from the cell edge (0  m) into the cell center. Fluorescence intensity of Arp3 (F) or ADF/cofilin
(G) and F-actin staining in control and skTM-injected cells measured from the cell edge (0  m) into the cell center. In E–G, data are averaged from 13 cells
per treatment, three measurements per cell. 
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We used kymograph analysis of F-actin FSM movies
(Video 1) to characterize F-actin kinematics (Fig. 4, C and D)
and their segregation into spatially distinct regions (Fig. 4 G and
Table I). In control cells, F-actin underwent fast retrograde flow
(0.688 
 
 
 
 0.334 
 
 
 
m/min, 
 
n
 
 
 
  
 
5 cells, 137 measurements) in a
band 1.57 
 
 
 
 0.09-
 
 
 
m-wide at the leading edge, typical of a
lamellipodium. In a 11.7 
 
 
 
 0.8-
 
 
 
m-wide region behind the
lamellipodium, F-actin exhibited lamella signature kinematics
characterized by slow retrograde flow (0.253 
 
 
 
 0.138 
 
 
 
m/min;
Fig. 4 G, 
 
n
 
 
 
 
 
 5 cells, 163 measurements). An F-actin conver-
gence rate of 0.44 
 
 
 
m/min was calculated by summing the aver-
age rate of lamella retrograde and cell body anterograde flow
(0.19 
 
 
 
 0.26 
 
 
 
m/min; Fig. 4 G, 
 
n
 
 
 
  
 
5 cells, 158 measurements).
In contrast to control cells, cells with skTM had only one
distinct region of F-actin kinematics at the cell edge. This 12.8 
 
 
 
0.9-
 
 
 
m-wide region exhibited retrograde flow at 0.885 
 
 
 
 0.264
 
 
 
m/min (
 
n
 
 
 
  
 
4 cells, 138 measurements; Fig. 4, D and G; and
Video 1), which is not significantly different from the lamellipo-
dium rate of control cells. The rapid F-actin retrograde flow met
increased anterograde flow (0.25 
 
 
 
 0.17 
 
 
 
m/min, 
 
n
 
 
 
  
 
4 cells, 42
measurements), resulting in an F-actin convergence rate three
times faster than control cells (1.14 
 
 
 
m/min). The convergence
zone, defined by the lack of directed F-actin movement, was three
times wider in skTM-containing cells than in controls (Table I).
Because molecular localization and qFSM kinetic analyses
suggested skTM inhibited lamellipodium formation, whereas ki-
nematic kymograph analysis suggested lamella inhibition, we
used drug sensitivity to identify the mechanism driving retro-
grade flow to clarify this controversy. Retrograde flow in the
lamellipodium is dependent on F-actin treadmilling as it is inhib-
ited by cytochalasin D and jasplakinolide, which are drugs that
modulate F-actin assembly/disassembly, and is unaffected by
drugs that inhibit myosin II activity, whereas lamella retrograde
flow is sensitive to myosin II inhibitors (Gupton et al., 2002;
Ponti et al., 2004). Retrograde flow in cells containing skTM was
unaffected by cytochalasin D (Fig. 4 E) but was immediately ar-
rested by blebbistatin (Fig. 4 F), indicating the single region of
F-actin kinematics was myosin II dependent and therefore opera-
tionally defined as a lamella. However, the rate of lamella retro-
grade flow in cells containing skTM was 
 
 
 
3.5 times faster than
lamella flow in control cells (Fig. 4 G, P 
 
  
 
0.0001).
 
skTM-induced changes in F-actin 
kinematics are due to increased myosin II 
decoration of F-actin
 
To determine if the increased rate of F-actin retrograde flow and
convergence in cells containing skTM was due to altered myosin
II recruitment, myosin IIA heavy chain and F-actin were local-
ized in control and skTM-injected cells. In control cells, myosin
IIA was excluded from the lamellipodium (Ponti et al., 2004),
and appeared in a gradient of punctae within the lamella (Fig. 5
A; Verkhovsky et al., 1995). In cells containing skTM, myosin
IIA punctae often extended all the way to the leading edge of the
cell (Fig. 5 B), mirroring skTM distribution (Fig. 1 E). The ratio
of myosin IIA/F-actin from the leading edge toward the cell cen-
ter was quantified by line scan analysis, indicating cells with
skTM have increased myosin II levels at their cell edges (Fig. 5,
C and D, three measurements per cell, 14 cells per treatment).
 
A lamellipodium is dispensable for 
persistent protrusion and cell migration 
in the presence of high levels of skTM
 
Changes in localization of signature molecules, F-actin kinetic
analysis, and drug sensitivity of F-actin kinematics suggests that
skTM inhibits lamellipodium formation, leaving behind a lead-
ing edge lamella with increased myosin II–dependent F-actin
flow. We cannot rule out that lamellipodia, which are very tran-
sient or not resolvable by our criteria, still exist, but we suggest
that such possible residual lamellipodia would make minimal
contribution to cell behavior. To test whether or not the lamelli-
Figure 3. skTM decreases the concentration of polymerization-competent free barbed filament ends at the cell edge. Barbed-end actin incorporation (green)
and fluorescent phalloidin (red) in a control cell (A) and an skTM-injected cell (B). (C) Intensity ratio of fluorescent actin incorporation marking free barbed fila-
ment ends relative to F-actin. (D) Intensity of fluorescent actin incorporation marking free barbed ends and F-actin staining. Profiles in C and D were measured
from line scans taken from the cell edge (0  m) into the cell center and data are averaged from 14 cells per treatment, three measurements per cell. 
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podium is required for cell motile function, we used phase-con-
trast microscopy to analyze leading edge behavior and migra-
tion velocity of cells containing skTM (Video 3, available at
http://www.jcb.org/cgi/content/full/jcb.200406063/DC1). Lead-
ing edge protrusion and retraction were analyzed by kymograph
(Table II and Fig. 6) and showed that rates in control and skTM-
injected cells were not significantly different (Table II). How-
ever, cells injected with skTM exhibited a twofold increase in
protrusion persistence time and a decreased retraction persistence
compared with controls (Table II). In contrast, cells expressing
the CA domain of N-Wasp, which inhibits Arp2/3 (Brieher et al.,
2004; Strasser et al., 2004), have similar protrusion persistence as
controls, although the rate of protrusion is significantly slower.
Analysis of cell velocity demonstrated that islands in which all
cells were injected with skTM migrated twice as fast (
 
n
 
 
 
  
 
113
cells) as islands of controls (
 
n
 
 
 
 
 
 73 cells, P 
 
  
 
0.0001; Table II
and Fig. 6). In contrast, inhibition of lamellipodium formation
with CA resulted in cell motility indistinguishable from controls.
 
Changes in cell migration correlate with 
changes in substrate adhesion distribution 
and dynamics and cytoplasm viscoelasticity
 
One hypothesis to explain enhanced migration of cells contain-
ing skTM is by contraction-mediated promotion of adhe-
sion distribution and/or turnover (Chrzanowska-Wodnicka and
Burridge, 1996; Webb et al., 2004). In controls, the adhesion
marker paxillin was in plaques at the ends of F-actin bundles
likely at the lamellipodium–lamella junction (Ponti et al., 2004;
Fig. 7 A). In cells containing skTM, paxillin also localized to
punctae along bundles in the cell body (Fig. 7 B, arrowhead;
Figure 4. skTM inhibits the formation of the
lamellipodium. (A) F-actin turnover maps com-
puted from qFSM time-lapse movies and corre-
sponding phase-contrast images in a control,
an skTM-injected (skTM), and a GFP-CA-
expressing (GFP-CA) cell. Turnover maps de-
pict polymerization (red) and depolymeriza-
tion (green) rates. Control cells exhibit narrow
bands of fast polymerization and depolymer-
ization in the lamellipodium adjacent to the
leading edge (arrow) and spatially random
punctae of polymerization and depolymeriza-
tion in the lamella. Cells containing skTM or
GFP-CA exhibit lamella F-actin kinetics at their
edges (arrows). (B) FSM image of F-actin in a
control PtK1. White line shows location used to
generate kymograph in C. (C and D) Kymo-
graphs of a control (C) and an skTM-injected
(D) cell; white lines highlight speckle transloca-
tion used to calculate flow velocities. There
are two regions of distinct retrograde flow
rates in controls and only one region of retro-
grade flow in cells containing skTM. (E and F)
Kymographs taken from F-actin FSM time series
of skTM-containing cells. In E, at the first arrow-
head, 200 nM cytochalasin D was perfused
and washed out at the second arrowhead.
Arrows illustrate leading edge protrusive be-
havior; lines emphasize retrograde flow rates.
In cytochalasin D, leading edge protrusion
stops, but retrograde F-actin flow continues. In
F, 100  M blebbistatin was perfused at the
arrowhead; lines emphasize actin flow rates.
After treatment, retrograde and anterograde
F-actin flow immediately arrested. (G) Average
F-actin flow rates in different cellular regions
taken from kymographs of control (blue) and
skTM-injected cells (red) (bars equal SEM).
Negative and positive flow rates imply retro-
grade and anterograde flow, respectively.
Convergence rate is the sum of the absolute
value of average lamella retrograde flow and
cell body anterograde flow. 
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and Video 4, available at http://www.jcb.org/cgi/content/full/
jcb.200406063/DC1), suggesting their engagement to the sub-
strate at sites along their lengths. In addition, adhesions were
located 36% closer to the leading edge (1.9 
 
 
 
 0.16 
 
 m) com-
pared with control cells (2.6   0.16  m, P   0.003; Fig. 7 C)
and were more dynamic than in control cells (Video 4, arrows).
One possible explanation for enhanced protrusive persis-
tence of cells containing skTM is changes in the stiffness of the
lamella actin network. To investigate the mechanical properties
of the cytoplasm we used intracellular microrheology to probe
in situ local intracellular viscoelasticity. This force-free method
transforms measured Brownian displacements of injected mi-
crospheres in the cytoplasm (Fig. 8, A and B) into local viscous
and elastic moduli (Mason et al., 1997; Apgar et al., 2000; Das-
gupta et al., 2002). This revealed a greater than fivefold (P  
0.05) increase in the stiffness of the lamella of skTM-injected
cells compared with controls (Fig. 8 C).
Endogenous long TMs organize 
actomyosin contractility
To investigate the role of endogenous TM, we inhibited long
TMs by microinjecting a long TM-specific monoclonal anti-
body (TM311; Nicholson-Flynn et al., 1996) that recognized a
single band of  39 kD (Fig. 1 B) and immunolocalized along
F-actin bundles and in punctae in the lamella of controls (Fig. 1 D
and Fig. 9 A). In contrast, injected TM311 antibody did not lo-
calize to F-actin structures but was diffuse in the cytoplasm (Fig.
9 B), suggesting the antibody inhibited TM–F-actin interactions.
In addition, injected cells had decreased density and straightness
of F-actin bundles in the cell center (Fig. 9, A and B).
Kymograph analysis of F-actin FSM movies showed an-
tibody inhibition of long TMs decreased lamella retrograde
flow rate 35% compared with control (0.17   0.072 vs. 0.26  
0.127  m/min, P   0.0001), decreasing the F-actin conver-
gence rate (Fig. 9 C). In addition, TM inhibition altered protru-
sion directional persistence, which was normally confined to
one leading edge over many hours. Cells with inhibited long
TMs sent out multiple protrusions that switched from site to
site over the course of minutes (Video 5, available at http://
www.jcb.org/cgi/content/full/jcb.200406063/DC1). Immuno-
staining of antibody-injected cells showed no obvious changes
in the localization and distribution of Arp2/3, ADF/cofilin, or
myosin II (unpublished data).
Discussion
Cell migration without a lamellipodium
In this paper, we showed that introducing high levels of skTM
into migrating epithelial cells caused major alterations in the
organization and dynamics of the actin cytoskeleton, which
Table I. skTM changes the organization of kinematically distinct regions of the actin cytoskeleton
Lamellipodium width Lamella width Convergence zone width
 m  m  m
Control cells
n   5 cells
1.57   0.09
n   132 measurements
11.7   0.8
n   66 measurements
5.3   0.16
n   134 measurements
skTM cells
n   5 cells
0
n   106 measurements
12.8   0.9
n   54 measurements
15.4   0.86
n   80 measurements
P-value  .0001 0.66  .0001
Width measurements of each region were made from kymographs of F-actin FSM movies and averaged for multiple measurements (five cells per treatment,
approximately three kymographs per cell). Regions were defined by the rate and drug sensitivity of their retrograde flow (see text). Numbers are averages   SEM.
Figure 5. skTM recruits myosin IIA to the leading edge. Immunolocalization of myosin IIA heavy chain and fluorescent phalloidin staining of F-actin in a
control (A) and an skTM-injected (B) PtK1 cell. The insets are magnified in the right column, with F-actin red and myosin IIA green. (C) Intensity ratio of
myosin IIA/F-actin in control and skTM-injected cells measured from the cell edge (0  m) into the cell center. (D) Fluorescence intensity of myosin IIA and
F-actin staining in control and skTM-injected cells measured from the cell edge (0  m) into the cell center. In C and D, data are averaged from 14 cells,
three measurements per cell.JCB • VOLUME 168 • NUMBER 4 • 2005 626
translated into changes in cell morphology and migratory be-
havior. Specifically, skTM inhibited the formation of the lead-
ing edge lamellipodium as determined by several criteria:
displacing its signature molecules Arp2/3 and ADF/cofilin; in-
hibiting the signature F-actin kinetics of juxtaposed bands of
polymerization/depolymerization at the cell edge; and inhibit-
ing the cytochalasin-sensitive region of F-actin retrograde flow
kinematics. Loss of the lamellipodium allowed the lamella
F-actin array to extend to the cell edge. Although we cannot
rule out that a lamellipodium that is transient or not resolvable
by our criteria still exists, cells containing skTM with inhibited
lamellipodia exhibited persistent leading edge protrusion and
rapid cell migration, indicating a lamellipodium and rapid actin
treadmilling at the leading edge are unnecessary for these cell
motile functions. This finding was corroborated by inhibition
of lamellipodium formation by disruption of Arp2/3 complex
function with the CA domain of WASP. Because our results in-
dicate that a lamellipodium is dispensable for leading edge pro-
trusion and migration, we suggest that the lamellipodium may
be required for exploring the environment or providing rapid
response to directional cues, but that the lamella is important
for productive cell movement.
skTM displaced Arp2/3 and cofilin, normally concen-
trated in the lamellipodium, and increased F-actin concentra-
tion. The displacement of Arp2/3 and cofilin is consistent
with the ability of TMs to block the actin branching or sever-
ing activities of these proteins in vitro (Bernstein and Bam-
burg, 1982; Blanchoin et al., 2001; DesMarais et al., 2002),
whereas increased F-actin may be due TM’s ability to prevent
pointed end depolymerization in vitro (Broschat, 1990). The
loss of Arp2/3 and cofilin correlated with decreased concen-
tration of free barbed filament ends at the cell edge and the
loss of the narrow, rapidly treadmilling actin array. This find-
ing suggests that Arp2/3 and cofilin mediate the lamellipo-
dium kinetic signature. Arp2/3 s involvement in this was
corroborated by its inhibition with CA. Inhibition of the
lamellipodium by both skTM or CA promoted filopodial pro-
trusions, suggesting that filopodia can arise by an Arp2/3-
independent pathway, such as filament elongation mediated
by Mena/VASP (Lebrand et al., 2004).
skTM also enhanced myosin II concentration in the
lamella and promoted its accumulation at the cell edge where
it is normally excluded. The increased myosin concentration
correlated with increased F-actin convergence between the
lamella and cell body. This suggests that myosin II recruited
to F-actin by skTM was active, which is consistent with struc-
tural studies in which activated myosin II bound to skTM-sat-
urated F-actin in the absence of troponin (Lehman et al.,
1995). skTM also promoted the rapid formation and turnover
of substrate adhesions closer to the cell edge. This is likely
Figure 6. skTM increases leading edge protrusion
persistence and cell migration velocity. Phase-contrast
images (left column) and kymographs (right two col-
umns) taken from movies of leading edges of control
cells (top row) and skTM-injected cells (bottom row).
White lines depict locations used to generate kymo-
graphs. Arrowheads delineate the beginning of each
retraction phase. Graph displays average instanta-
neous cell migration velocity in control, skTM-injected
(skTM), and GFP-CA (CA)–expressing PtK1 cell islands.
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not a direct effect of skTM on integrin activation but a prod-
uct of enhanced actomyosin promotion of substrate adhesion
turnover (Chrzanowska-Wodnicka and Burridge, 1996; Webb
et al., 2004). Paxillin punctae were also along central F-actin
bundles in cells containing skTM, suggesting that faster mi-
gration of these cells was due to increased engagement of my-
osin II contractility along F-actin bundles spanning between
the lamella and cell body, which were engaged to the sub-
strate at sites along their length, allowing the cell to pull itself
forward more efficiently.
How does the leading edge of cells lacking a lamellipo-
dium still move forward? One possibility is that increased con-
traction in the cell center and rear could squeeze a pliant leading
edge forward by hydrostatic pressure, as may occur in leuko-
cyte or amoeboid movement (Hartwig et al., 1983; Fukui,
1993). However, this possibility disagrees with our microrheo-
logical demonstration of increased stiffness in the lamella and
our EM analysis showing increased density and bundling of fil-
aments in the lamella of cells containing skTM. Leading edge
protrusion in cells containing skTM still requires actin polymer-
ization from barbed ends because protrusion was blocked by
cytochalasin D (Fig. 4 G). Thus, there must be either an al-
ternative Arp2/3- and ADF/cofilin-independent mechanism for
barbed-end production, sufficient preexisting barbed ends that
are protected from capping, or enough residual Arp2/3 and
ADF/cofilin activity to allow adequate actin polymerization for
leading edge protrusion. This could be mediated by a “leaky
cap” such as formin or Mena/Vasp protected filaments (Bear et
al., 2002; Zigmond, 2004). Filament elongation likely occurs
from stiff skTM-coated (Kojima et al., 1994) and myosin
II–cross-linked lamella F-actin, whose rigidity would allow
monomer addition at the leading edge to overcome membrane
Table II. skTM increases protrusion persistence and cell migration rates
Control cells skTM cells CA cells
Protrusion time 28.3   2.9 s
n   28 measurements
8 cells
58.7   7.9 s
n   30 measurements
10 cells
P   0.0009
28.5   2.6s
n   68 measurements
15 cells
P   0.09
Retraction time 49.8   7.4 s
n   32 measurements
8 cells
27.6   3.2 s
n   30 measurements
10 cells
P   0.002
42.4   4.7s
n   66 measurements
15 cells
P   0.2
Protrusion rate 0.69   0.06 mm/min
n   81 measurements
8 cells
0.88   0.14 mm/min
n   36 measurements
10 cells
P   0.3
0.23   0.2 mm/min
n   68 measurements
15 cells
P   0.08
Retraction rate 0.58   0.06 mm/min
n   64 measurements
8 cells
0.53   0.07
n   26 measurements
10 cells
P   0.66
0.13   0.01 mm/min
n   66 measurements
15 cells
P   0.06
Protrusion initiation frequency 0.85/min 2.4/min 1.0/min
Retraction initiation frequency 2.8/min 0.86/min 1.2/min
Cell migration rate 0.59   0.01 mm/min
n   73 cells
1.22   0.02 mm/min
n   113 cells
P   0.0001
0.48   0.01 mm/min
n   9 cells
Quantification of leading edge dynamics was made from kymographs of phase-contrast image series acquired at 10-s intervals (Fig. 6). Cell migration rates were
measured from the position of the nucleus over time in phase-contrast image series acquired at 2-min intervals. Numbers are averages   SEM.
Figure 7. Substrate adhesions form closer to the leading edge in cells containing skTM. F-actin staining (fluorescent phalloidin, red) and paxillin immunolocal-
ization (green) in control (A) and skTM-injected (B) cells. Arrowhead in B shows paxillin punctae along central F-actin bundles that are not present in F-actin in A.
(C) Frequency histogram of the distance of the distal-most border of paxillin foci from the leading edge in control and skTM-injected cells (n   8 cells, 10–15
measurements per cell per treatment). Numbers in the top right of graph are the mean distance (  SEM) of the adhesion sites from the cell edge.JCB • VOLUME 168 • NUMBER 4 • 2005 628
tension as is thought to occur in the dendritic meshwork assembly
model (Mullins et al., 1998; Mogilner and Oster, 2003). Indeed,
studies of Listeria monocytogenes and bead motility in vitro
have shown that a dendritic meshwork is not necessary for poly-
merization-based propulsion if the F-actin is cross-linked by
proteins such as fascin or  -actinin (Brieher et al., 2004) or
polymerization is mediated by mdia (Romero et al., 2004).
Long TMs organize and maintain 
contraction
Inhibition of endogenous long TM function by TM311 anti-
body injection changed the contractile and protrusive be-
havior of the cell in ways that contrasted the effects induced
by excess skTM. Long TM inhibition reduced F-actin con-
vergence and induced misdirected protrusions with low
directional persistence. In contrast, skTM-containing cells
showed enhanced F-actin convergence and protrusion per-
sistence. Thus, endogenous long TMs are likely critical to
organizing actomyosin and promoting contraction in central
cell regions, which in turn restricts lamellipodium formation
to a specific persistent site at the cell edge. Previous stud-
ies suggest different isoforms of TMs segregate spatially,
which may lead to spatial and functional specialization of
subsets of the F-actin cytoskeleton, as occurs in cell migra-
tion (Temm-Grove et al., 1998; Bryce et al., 2003). Thus,
we suggest TM is important for regionally defining the mo-
lecular, kinetic, and kinematic properties of the actin cyto-
skeleton, which can mediate changes in cell morphology
and migration.
Materials and methods
Cell culture and microinjection
PtK1 cells were cultured as described previously (Wittmann et al., 2003).
X-rhodamine–conjugated actin was prepared as described previously (Wa-
terman-Storer, 2002) and microinjected into cells at 1 mg/ml. Rabbit skele-
tal muscle TM (predominately  TM) was purified from psoas muscle as de-
Figure 8. skTM enhances the stiffness of the
lamella. Phase-contrast micrographs of a con-
trol cell (A) and an skTM-injected cell (B)
overlaid marks corresponding to the positions
of fluorescent microspheres that were injected
into the cell. Particle loci are color coded ac-
cording to the local value of the cytoplasmic
elasticity from red (softest) to blue (stiffest). (C)
Relative elasticity of the cell body (CB) and
lamella (LM) of control and TM-injected cells
calculated at a sampling frequency of 1 Hz.
Graph shows mean elasticity (  SEM); differ-
ences in elasticity are significant (P   0.05).
Figure 9. Antibody inhibition of long TM isoforms displaces TM from F-actin and decreases myosin II–dependent F-actin convergence. (A and B) F-actin
(fluorescent phalloidin) and long isoforms of TM (TM 311 antibody) in control (A) and cells injected with TM311 antibody (B).  In control cells, long TM
localizes along F-actin bundles, but is displaced from F-actin bundles in TM311 antibody–injected cells. Right column shows a magnified view of TM in the
boxed regions. (C) Average F-actin flow rates   SEM in control and TM311-injected cells with negative and positive rates indicating retrograde and
anterograde flow, respectively.CELL MIGRATION WITHOUT A LAMELLIPODIUM • GUPTON ET AL. 629
scribed previously (Bailey, 1948) and microinjected at 140  M. TM311
antibody (Sigma-Aldrich) was microinjected at 1 mg/ml. For experiments
requiring expression of GFP-labeled proteins, fluorescent actin, skTM, and
the DNA plasmid at 1 mg/ml were comicroinjected into the nucleus.
Live cell and immunofluorescence microscopy
Cells were maintained on the microscope stage at 37 C with an air
stream incubator (Nevtek) in aluminum chambers (Wittmann et al., 2003)
in culture medium containing 30  l oxyrase per milliliter of media (Oxy-
rase, Inc.) to inhibit photobleaching.
F-actin FSM, GFP fluorescence, and phase-contrast time-lapse im-
age series were acquired at 5- to 10-s intervals using a 100   1.4 NA
Plan Apo phase-contrast objective lens (Nikon) on a spinning disk confo-
cal scanner (Yokogawa) described in Adams et al. (2003). For drug treat-
ments, cells were imaged in a stainless steel perfusion chamber (Gupton
and Waterman-Storer, 2005) and treated with either 100  M blebbistatin
or 200 nM cytochalasin D.
Leading edge activity and cell migration rates were determined
from phase-contrast time series acquired on an inverted microscope
(model TE300; Nikon) equipped with electronically controlled shutters and
a robotic stage with linear position feedback encoders on the x, y, and z
axes (model MS-2000; Applied Scientific Instruments). Images were ac-
quired on a 12-bit cooled CCD camera (model Orca 285; Hamamatsu)
controlled by MetaMorph software (Universal Imaging Corp.) using a 20  
0.5 NA Plan Apo phase-contrast objective lens (Nikon). For cell velocity
measurements, images were captured every 2 min for 5 h, whereas for
leading edge characterization images were taken every 10 s for 10 min.
Epifluorescence images of fixed cells were acquired on an inverted
microscope (model TE300 Quantum; Nikon) equipped with a triple band
pass dichroic mirror and a 14-bit cooled CCD camera (model Orca II;
Hamamatsu) controlled by MetaMorph software using a 60 /1.4 NA
Plan Apo DIC objective lens (Nikon).
Immunofluorescence and quantification of polymerization-competent free 
barbed ends
Control and skTM-injected cells were fixed in cytoskeletal buffer (10 mM
MES, 3mM MgCl2, 138 mM KCl, and 2 mM EGTA, pH 6.9) contain-
ing 4% PFA, permeabilized in cytoskeletal buffer containing 0.5% Triton
X-100, and immunolabeled for the following: long isoforms of TM (TM311;
Sigma-Aldrich); all TM isoforms (polyclonal RB14; Ursitti and Fowler,
1994); injected rabbit skeletal muscle TM (CH1; Sigma-Aldrich), paxillin
(Signal Transduction Laboratories), mDia2 (a gift from A. Alberts, Van An-
del Research Institute, Grand Rapids, MI), Mena and VASP (a gift from F.
Gertler, Massachusetts Institute of Technology, Cambridge, MA), ADF/cofi-
lin (Cytoskeleton), or Arp3 (a gift from M. Welch, University of California,
Berkeley, Berkeley, CA) using the appropriate fluorescently labeled sec-
ondary antibodies (Jackson ImmunoResearch Laboratories). For myosin IIA
heavy chain immunofluorescence (Biomedical Technologies, Inc.), cells
were processed as previously described (Cramer and Mitchison, 1995).
F-actin was labeled with fluorescent phalloidin. To localize and quantify
the relative number of actin filament free barbed ends, live cells were perme-
abilized with 0.25 mg/ml saponin in the presence of 0.5  M X-rhodamine
actin and fixed as previously described (Symons and Mitchison, 1991).
Image analysis and quantification
F-actin flow rates in each cellular region were measured by kymograph
analysis as previously described (Salmon et al., 2002). F-actin polymeriza-
tion and depolymerization maps were calculated using qFSM software
(Ponti et al., 2003; Vallotton et al., 2003). In brief, this software identifies
F-actin speckles as diffraction-limited intensity peaks that are significantly
different from image noise. Speckle appearance, intensity fluctuations, and
time of disappearance are then determined to allow calculation of maps of
the relative rates of actin filament depolymerization and polymerization.
The output of this algorithm represents polymerization in a red scale and
depolymerization in a green scale, with bright red and bright green depict-
ing fast polymerization and fast depolymerization, respectively.
To analyze immunofluorescence data, fluorescence intensity was
measured along multiple 50-pixel-wide regions (three to four per cell
spaced at even intervals along leading edge) normal to the leading edge
from the cell edge into the cell center. The averages from multiple regions
in multiple cells were calculated and plotted against distance from the
leading edge. The distance between the distal border of substrate adhe-
sions and cell edge was measured from paxillin immunofluorescence im-
ages. All measurements were made from controls and skTM-injected cells
plated on the same coverslip.
For kymograph analysis of leading edge behavior, four to eight ran-
domly placed lines normal to the free cell edge were used. Leading edge
protrusion and retraction rates, frequencies of switching between phases,
and time of protrusion or retraction persistence were calculated from these
kymographs. Velocities of cells in small islands (3–6 cells/island) com-
prised exclusively of either controls, skTM-injected cells, or CA-expressing
cells were measured using the track objects function in MetaMorph.
Intracellular cytomechanics using particle tracking microrheology
The intracellular elasticity was measured using the method of particle
tracking microrheology introduced by Tseng et al. (2002). 100-nm-diam
carboxylated fluorescent polystyrene nanospheres (Molecular Probes)
were microinjected into cells with or without skTM (Kole et al., 2004). Mov-
ies of the thermally excited Brownian displacements of the beads were re-
corded by time-lapse microscopy using a CCD camera (model Orca II;
Hamamatsu) on an epifluorescence microscope (model TE300; Nikon).
The coordinates of the particles’ centroids were monitored with a spatial
resolution of  10 nm and a temporal resolution of 0.1 s and transformed
into mean square displacements using a subroutine incorporated into
MetaMorph. Mean square displacements were mathematically transformed
into a local cytoplasmic elasticity (Mason et al., 1997), which describes
the propensity of the local network in the vicinity of the probe nanospheres
to resist the random mechanical stresses generated by the Brownian
motion.
Immunoblot analysis
PtK1 cells were lysed in sample buffer and subjected to SDS-PAGE followed
by immunoblotting. The CG3 mAb reacts with the exon 1b–encoded NH2
terminus products of the TM5 gene in short nonmuscle TMs (a gift from J.
Lin, University of Iowa, Iowa City, IA; Lin et al., 1985), the CH1 monoclo-
nal reacts with striated muscle TM (Lin et al., 1985), the RB14 polyclonal
recognizes all TM isoforms, and the TM311 monoclonal (Sigma-Aldrich)
recognizes an epitope within residues 14–32 in all long TM isoforms but
doesn’t cross-react with short TMs (Nicholson-Flynn et al., 1996).
Electron microscopy
PtK1 cells were grown for 5 d on carbon-coated formvar 100 mesh finder
grids (EMS). Control cells and skTM-injected cells were fixed in 100 mM
Pipes, pH 6.9, 1 mM MgSO4, 1 mM EGTA buffer containing 2% PFA,
and 0.05% glutaraldehyde, washed, and stained with aqueous 2% OsO4
and 2% uranyl acetate. Dehydration in increasing concentrations of re-
agent grade ethanol (15, 20, 50, 70, 95, and 100%; 3 min per change)
was followed by critical-point drying according to Anderson (1951) and
Buckley and Porter (1975). Images were obtained under low-dose condi-
tions using a microscope (model Tecnai 12; FEI electron optics) equipped
with a Lab6 filament (Denka) at 120 kV. Tilt angles from  15 to  20 
were used for the stereo-pair images. Kodak SO-163 plates were devel-
oped for 13 min in (1:1) D19 developer (Eastman Kodak Co.).
Online supplemental material
Fig. S1 depicts stereo pairs showing a portion of the leading edge of con-
trol and skTM-injected cells from the same cell cluster. Fig. S2 shows that
Mena, VASP, and mDia2 localization are similar in control and skTM-
injected cells. Fig. S3 shows that high levels of skTM do not alter filamin
and cortactin distribution. Video 1 shows that cells containing skTM ex-
hibit only one region of F-actin kinematic behavior at their leading edges.
Video 2 shows that high levels of skTM inhibit the kinetic signature of the
lamellipodium. Video 3 shows that high levels of skTM induce multiple
filopodial protrusions from the cell edge. Video 4 shows that high levels of
skTM induce changes in distribution and dynamics of paxillin containing
substrate adhesions. Video 5 shows that cells with inhibited TM exhibit
decreased lamellipodial protrusion persistence. The online supplemen-
tal material is available at http://www.jcb.org/cgi/content/full/jcb.
200406063/DC1.
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